Adenovirus Vector-Mediated Gene Transfer Using Degradable Starch Microspheres for Hepatocellular Carcinoma in Rats

Journal of Surgical Research

Volumn 133, Issue 2, 2006, Pages 193-196

  Shiba, Hiroaki ^a   Okamoto, Tomoyoshi ^a   Futagawa, Yasuro ^a   Misawa, Takeyuki ^a   Yanaga, Katsuhiko ^a   Ohashi, Toya ^a   Eto, Yoshikatsu ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

adenovirus vector; arterial injection; degradable starch microspheres; gene transfer; hepatocellular carcinoma; rat

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; DIETHYLNITROSAMINE; MICROSPHERE; PHENOBARBITAL; STARCH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; HEPATIC ARTERY; HISTOPATHOLOGY; IMAGE ANALYSIS; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MICROPHOTOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADENOVIRIDAE; ANIMALS; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEPATIC ARTERY; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MICROSPHERES; RATS; RATS, WISTAR; STARCH;

EID: 33646872851     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.10.023     Document Type: Article

References (21)

1. Ravoet C., Bleiberg H., and Gerard B. Non-surgical treatment of hepatocellular carcinoma. J Surg Oncol 3 Suppl (1993) 104
2. Venook A.P. Treatments of hepatocellular carcinoma. too many options?. J Clin Oncol 12 (1994) 1323
3. Bilbao R., Bustos M., Aluzguren P., Pajares M.J., Drozdzik M., Qian C., et al. A blood-tumor barrier limits gene transfer to experimental liver cancer. The effect of vasoactive compounds. Gene Ther 7 (2000) 1824
4. Gerolami R., Gardoso J., Bralet M.P., Cuenod C.A., Clement O., Tran P.L., et al. Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery. Gene Ther 5 (1998) 896
5. Takayasu K., Muramatsu Y., Mizuguchi Y., Moriyama N., and Ojima H. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic CT and a combination of CT and angiography. experience with resected liver specimens. Intervirology 47 (2004) 199
6. Konno T., Maeda H., Iwai K., Tashiro S., Maki S., Morinaga T., et al. Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma. Eur J Cancer Clin Oncol 19 (1983) 1053
7. Konno T., Maeda H., Iwai K., Maki S., Tashiro S., Uchida M., et al. Selective targeting of anticancer drug and simultaneous image enhancement in solid tumor by arterially administered lipid contrast medium. Cancer 54 (1984) 2367
8. Maki S., Konno T., and Maeda H. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 56 (1985) 751
9. Shiba H., Okamoto T., Futagawa Y., Ohashi T., and Eto Y. Efficient and cancer-selective gene transfer to hepatocellular carcinoma in a rat using adenovirus vector with iodized oil esters. Cancer Gene Ther 8 (2001) 713
10. Ensminger W.D., Gyves J.W., Stetson P., and Walker S. Phase 1 study of hepatic arterial degradable starch microspheres and mitomycin. Cancer Res 45 (1985) 4464
11. Grandin C., Van Beers B.E., Demeure R., Goudemant J.F., Mottet I., and Pringot J. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA-enhanced magnetic resonance imaging of hepatocarcinoma in the rat. Invest Radiol 30 (1995) 572
12. Ni Y., Marchal G., Yu J., Lukito G., Petre C., Wevers M., et al. Localization of metalloporphyrin-induced "specific" enhancement in experimental liver tumors. comparison of magnetic resonance imaging, microangiographic, and histologic findings. Acad Radiol 2 (1995) 687
13. Kanegae Y., Lee G., Sato Y., Tanaka M., Sakaki T., and Sugano S. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific cre recombinase. Nucleic Acids Res 23 (1995) 3816
14. Tani K., Lin T., Hibino H., Takahashi K., Nakazaki Y., Takahashi S., et al. Transduction of LacZ gene into leukemia cells using viral vectors of retrovirus and adenovirus. Leukemia 9 Suppl 1 (1995) S64
15. Niwa H., Yamamura K., and Miyazaki Y. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 (1991) 193
16. Kanegae Y., Makimura M., and Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47 (1994) 157
17. Than T.T., Sitzmann J.V., Li S.S., Lin P.W., and Grochow L.B. A method for hepatic arterial perfusion studies in the rat. J Surg Res 47 (1989) 251
18. Harris M.P., Sutjipto S., Wills K.N., Hancock W., Cornell D., Johnson D.E., et al. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther 3 (1996) 121
19. Qian C., Idoate M., Bilbao R., Sangro B., Bruna O., Vazques J., et al. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma. Hum Gene Ther 8 (1997) 349
20. Anderson S.C., Johnson D.E., Harris M.P., Engler H., Hancock W., Huang W., et al. p53 gene therapy in a rat model of hepatocellular carcinoma. Intra-arterial delivery of a recombinant adenovirus. Clin Cancer Res 4 (1998) 1649
21. Shinozaki K., Ebert O., and Woo S.L. Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSV. Hepatology 41 (2005) 196